Rapid improvement in affective information processing after acute administration of reboxetine.
Michael E
ME
Thase
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001933:Brain Stem / Q000187:drug effects; D003071:Cognition / Q000187:drug effects*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology / Q000628:therapy; D004644:Emotions / Q000187:drug effects*; D006801:Humans; D009025:Morpholines / Q000494:pharmacology* / Q000627:therapeutic use*; D011613:Psychotherapy / Q000379:methods; D000077593:Reboxetine; D013997:Time Factors; D016896:Treatment Outcome
D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D009025:Morpholines; D000077593:Reboxetine